LF. Santamaria-Babí

发表

Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.

E. Serra-Baldrich, J. Francisco Silvestre, LF. Santamaria-Babí, 2021, Actas dermo-sifiliograficas.